Ascend Says MedMen's 'Seller's Remorse' Can't Prop Up Suit
Cannabis giant Ascend has asked a New York state judge to dismiss counterclaims by erstwhile deal partner MedMen arising from a $73 million agreement between the companies that went south, saying...To view the full article, register now.
Already a subscriber? Click here to view full article